inflsp | 13685
Infliximab (Remicade®), level
| Material |
|
|
| Stability | 4 weeks / 2-8°C; 1 year / -20°C | |
| Duration | 1 - 2 weeks | |
| Frequency | 1 x per week | |
| Method | Enzyme Linked Immuno Sorbent Assay (ELISA) | |
| Price | CHF 49.50 | |
| Tariff | 49.50 TP | |
| LA position | 1470.00 | |
| Designation | Immunsuppressiva der SL/ALT | |
| Executing laboratory | External laboratory |
Reference values
| Value | Sex |
|---|---|
| 0.5 - 6 mg/L | f+m |
Team of consultants
|
Dr. sc. nat. ETH, FAMH Specialist in laboratory medicine, main fields medical microbiology, immunology
Diana Ciardo
Head of Specialty laboratories
|
Head of Specialty laboratories | T |
|
|
MSc Infection Biology
Siro Ellenberger
Candidate FAMH Specialist in laboratory medicine, main field immunology
|
Candidate FAMH Specialist in laboratory medicine, main field immunology | T |
|
|
PhD
Maurus Curti
FAMH Specialist in laboratory medicine
|
FAMH Specialist in laboratory medicine | T |
|
|
Dr. sc. nat.
Corinne Ruppen
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|